Predictive Model for Multiple Sclerosis Treatment Adherence
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining adherence to Multiple Sclerosis treatment, such as medication possession ratio, provide an incomplete and inaccurate understanding of patient adherence, failing to effectively predict future adherence and necessitate improved predictive models for resource allocation and intervention.
Innovation Solution
A system and method for predicting adherence to Multiple Sclerosis treatment using a predictive model that integrates member data, including adherence history, prescription data, family demographics, and consumer segmentation, to identify likely adherent and non-adherent patients, enabling early intervention and resource allocation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional adherence metrics such as medication possession ratio are used, then adherence measurement is simple and straightforward, but the accuracy and completeness of adherence understanding is insufficient
Solution Approach 1:
The patent combines multiple data sources including medication possession ratio, patient demographics, disease characteristics, treatment history, and social determinants of health into a unified predictive model. This integration of diverse metrics allows for more accurate adherence prediction while managing model complexity through systematic data synthesis.
Solution Approach 2:
The predictive model serves multiple functions: it predicts future adherence, identifies at-risk patients, and provides actionable insights for intervention. This multi-functional approach maximizes the utility of the model while justifying the complexity through its comprehensive application in improving patient outcomes.
2Reliability
If comprehensive predictive modeling is implemented, then future adherence prediction accuracy is improved, but resource requirements and system complexity increase
Solution Approach 1:
The system performs preliminary adherence prediction before clinical problems arise, allowing healthcare providers to identify at-risk patients in advance. This proactive approach enables early intervention and resource allocation to patients who need it most, improving both prediction reliability and resource efficiency.
Solution Approach 2:
The predictive model incorporates feedback loops where prediction results inform intervention strategies, and intervention outcomes refine future predictions. This continuous feedback mechanism improves prediction reliability over time while optimizing resource allocation based on actual patient responses.
Data Source
AI summary
Methods and systems for predicting adherence to Multiple Sclerosis treatment are described. In one embodiment, a member undergoing a Multiple Sclerosis treatment is identified. Member data associated with the member undergoing the Multiple Sclerosis treatment is accessed. Pre-prediction time period adherence data associated with the member, member prescription data associated with the member, member family data associated with the member, and member demographic data associated with the member are determined based on the member data associated with the member. A likelihood that the member will be adherent to the Multiple Sclerosis treatment over a prediction time period is determined based on the pre-prediction time period adherence data, member prescription data, member family data, and member demographic data. Other methods and systems are described.